Want to see HK:1863 full AI Analyst Report?
China Longevity Group Co. Ltd. (1863) Ratios
China Longevity Group Co. Ltd. Ratios
HK:1863's free cash flow for Q4 2025 was $-1.60M. For the 2025 fiscal year, HK:1863's free cash flow was decreased by $-54.30M and operating cash flow was $52.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.61 | 1.40 | 1.38 | 1.18 | 1.00 |
| Quick Ratio | 1.18 | 0.97 | 0.88 | 0.80 | 0.74 |
| Cash Ratio | 0.38 | 0.15 | 0.14 | 0.19 | 0.10 |
| Solvency Ratio | 0.10 | 0.10 | 0.12 | 0.15 | 0.20 |
| Operating Cash Flow Ratio | 0.23 | 0.19 | -0.02 | 0.07 | 0.23 |
| Short-Term Operating Cash Flow Coverage | 0.72 | 0.54 | -0.07 | 0.24 | 0.79 |
| Net Current Asset Value | $ -347.40M | $ -332.12M | $ -314.81M | $ -120.96M | $ -47.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.37 | 0.35 | 0.36 | 0.25 | 0.18 |
| Debt-to-Equity Ratio | 0.91 | 0.91 | 0.92 | 0.55 | 0.48 |
| Debt-to-Capital Ratio | 0.48 | 0.48 | 0.48 | 0.36 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.39 | 0.40 | 0.23 | 0.06 |
| Financial Leverage Ratio | 2.49 | 2.59 | 2.53 | 2.23 | 2.62 |
| Debt Service Coverage Ratio | 0.60 | 0.60 | 0.74 | 0.74 | 0.76 |
| Interest Coverage Ratio | 2.12 | 7.97 | 10.02 | 4.54 | 8.27 |
| Debt to Market Cap | 0.69 | 0.62 | 0.58 | 0.32 | 0.27 |
| Interest Debt Per Share | 0.87 | 0.81 | 0.74 | 0.41 | 0.32 |
| Net Debt to EBITDA | 5.13 | 4.69 | 4.35 | 1.98 | 0.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.37% | 17.40% | 19.92% | 15.79% | 18.08% |
| EBIT Margin | 3.36% | 5.89% | 7.76% | 6.69% | 9.26% |
| EBITDA Margin | 9.07% | 10.92% | 13.68% | 13.18% | 13.59% |
| Operating Profit Margin | 3.36% | 6.58% | 8.36% | 6.41% | 9.00% |
| Pretax Profit Margin | 3.63% | 5.06% | 6.92% | 5.27% | 8.18% |
| Net Profit Margin | 3.68% | 4.77% | 6.75% | 4.98% | 7.42% |
| Continuous Operations Profit Margin | 3.17% | 4.46% | 6.28% | 4.80% | 7.37% |
| Net Income Per EBT | 101.27% | 94.22% | 97.44% | 94.54% | 90.76% |
| EBT Per EBIT | 108.09% | 76.84% | 82.84% | 82.27% | 90.85% |
| Return on Assets (ROA) | 2.18% | 2.86% | 3.68% | 3.46% | 7.69% |
| Return on Equity (ROE) | 5.42% | 7.41% | 9.31% | 7.71% | 20.13% |
| Return on Capital Employed (ROCE) | 2.62% | 5.55% | 6.24% | 6.94% | 21.38% |
| Return on Invested Capital (ROIC) | 2.07% | 4.30% | 5.03% | 5.40% | 13.99% |
| Return on Tangible Assets | 2.18% | 2.86% | 3.69% | 3.47% | 7.69% |
| Earnings Yield | 4.12% | 5.06% | 5.95% | 4.48% | 11.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.21 | 3.12 | 3.80 | 5.11 | 4.40 |
| Payables Turnover | 3.77 | 3.17 | 3.09 | 2.83 | 2.43 |
| Inventory Turnover | 4.77 | 3.99 | 3.22 | 4.29 | 5.79 |
| Fixed Asset Turnover | 1.01 | 1.06 | 0.92 | 1.30 | 2.56 |
| Asset Turnover | 0.59 | 0.60 | 0.55 | 0.69 | 1.04 |
| Working Capital Turnover Ratio | 4.61 | 5.85 | 7.05 | 21.24 | -39.49 |
| Cash Conversion Cycle | 93.34 | 93.30 | 91.28 | 27.22 | -4.42 |
| Days of Sales Outstanding | 113.58 | 116.89 | 95.96 | 71.37 | 83.04 |
| Days of Inventory Outstanding | 76.57 | 91.54 | 113.39 | 85.02 | 63.00 |
| Days of Payables Outstanding | 96.81 | 115.13 | 118.07 | 129.17 | 150.47 |
| Operating Cycle | 190.15 | 208.44 | 209.35 | 156.39 | 146.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.13 | 0.12 | -0.01 | 0.04 | 0.21 |
| Free Cash Flow Per Share | 0.00 | -0.03 | -0.42 | -0.16 | 0.07 |
| Dividend Paid and CapEx Coverage Ratio | 1.02 | 0.81 | -0.03 | 0.20 | 1.46 |
| Capital Expenditure Coverage Ratio | 1.02 | 0.81 | -0.03 | 0.20 | 1.46 |
| Operating Cash Flow Coverage Ratio | 0.15 | 0.15 | -0.02 | 0.11 | 0.69 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.09 | -0.01 | 0.04 | 0.12 |
| Free Cash Flow Yield | 0.18% | -2.17% | -33.50% | -13.43% | 5.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.27 | 19.75 | 16.80 | 22.33 | 8.90 |
| Price-to-Sales (P/S) Ratio | 0.89 | 0.94 | 1.13 | 1.11 | 0.66 |
| Price-to-Book (P/B) Ratio | 1.32 | 1.46 | 1.56 | 1.72 | 1.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 565.97 | -45.98 | -2.99 | -7.45 | 17.05 |
| Price-to-Operating Cash Flow Ratio | 9.65 | 10.59 | -99.69 | 29.35 | 5.36 |
| Price-to-Earnings Growth (PEG) Ratio | -1.09 | -1.68 | 0.46 | -0.38 | 0.06 |
| Enterprise Value Multiple | 14.98 | 13.31 | 12.63 | 10.43 | 5.76 |
| Enterprise Value | 1.60B | 1.69B | 1.61B | 1.27B | 1.13B |
| EV to EBITDA | 14.98 | 13.31 | 12.63 | 10.43 | 5.76 |
| EV to Sales | 1.36 | 1.45 | 1.73 | 1.37 | 0.78 |
| EV to Free Cash Flow | 860.53 | -71.02 | -4.55 | -9.19 | 20.23 |
| EV to Operating Cash Flow | 14.67 | 16.36 | -151.98 | 36.23 | 6.36 |
| Tangible Book Value Per Share | 1.02 | 0.97 | 0.89 | 0.76 | 0.66 |
| Shareholders’ Equity Per Share | 0.94 | 0.88 | 0.79 | 0.70 | 0.62 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.12 | 0.09 | 0.09 | 0.10 |
| Revenue Per Share | 1.38 | 1.37 | 1.10 | 1.09 | 1.69 |
| Net Income Per Share | 0.05 | 0.07 | 0.07 | 0.05 | 0.13 |
| Tax Burden | 1.01 | 0.94 | 0.97 | 0.95 | 0.91 |
| Interest Burden | 1.08 | 0.86 | 0.89 | 0.79 | 0.88 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.13 | 0.09 | 0.08 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.52 | 1.76 | -0.16 | 0.72 | 1.51 |
Currency in CNY
